A study by Gene Solutions finds signals associated with preterm birth using routine triSure non-invasive prenatal testing (NIPT) data. The research reports that information generated during standard NIPT analysis may contain markers that can help identify pregnancies at higher risk of delivering preterm.
In context, NIPT is widely used to screen for fetal genetic conditions through analysis of maternal blood samples. The study focuses instead on pregnancy outcome signals, evaluating whether triSure results can be repurposed beyond screening. Across outlets, the emphasis is on the study’s claim that existing, routinely collected NIPT data may be used to flag preterm-birth risk, rather than requiring new testing approaches.
Both sources present the same core finding: Gene Solutions reports preterm-birth–related signals within regular triSure NIPT datasets. However, without additional reporting detail provided here, differences in study design, statistical performance, and clinical implementation are not specified.
